![]() Powered by the company’s patented GLYMATRIX® technology, OSSIX® Plus, OSSIX® Volumax, and OSSIX™ Bone are covered by over 100 scientific publications and extensive clinical experience with thousands of clinicians. The company was founded in 2012, has 50 employees and its headquarters is in Lod, close to Tel Aviv, Israel.ĭatum Dental is a leading provider of the innovative OSSIX® regenerative solutions portfolio. The company markets its products for dental professionals through its extensive global network of partners in over 40 countries worldwide. The transaction is expected to close in January 2021, following customary approval requirements.ĭatum Dental is an innovative Israel-based company for dental regeneration products with clinically superior proprietary technology. The strong OSSIX® portfolio will be the foundation of the Regenerative portfolio of Dentsply Sirona. Today, Dentsply Sirona is promoting the full OSSIX® portfolio (OSSIX® Plus, OSSIX® Volumax, and OSSIX™ Bone) in the U.S., Canada, Colombia, France, Belgium, UK-Ireland, Nordics, Poland, Romania, Turkey and Hong Kong.Ĭlinicians will benefit in the future from OSSIX® products’ being implemented in a broad set of solutions and workflows and Dentsply Sirona’s capacity to invest in the future development. Since 2016, Dentsply Sirona has already been in distribution agreements with Datum Dental. Our R&D pipeline will continue to develop new, safe and transformational solutions – that simplify procedures and overcome major deficiencies in existing biomaterial‐based regenerative products,” says Itay Itzhaky, Chief Executive Officer of Datum Dental. ![]() Dentsply Sirona offers us opportunities to work on continued innovation with the strongest R&D team in the industry. “We are pleased that the OSSIX® family is becoming part of the market leader in dental. The acquisition is another important step for us to deliver on our purpose to empower dental professionals to provide patients with better dental care and make people smile,” says Gene Dorff, Group Vice President Implants Product Group of Dentsply Sirona. The biomaterial sector is an important cornerstone of the future of dentistry. “Datum Dental perfectly fits in our strategy to deliver innovative and meaningful solutions for our customers. The OSSIX® dental regeneration products will support and enhance the future of implant dentistry and oral care. With innovative products driven by the GLYMATRIX® core technology, OSSIX® bio-durable design will ensure long-term predictable and superior results. With a track record of simplifying and developing innovations for regenerative procedures, the OSSIX® portfolio will support the vision to become one of the leaders in the dental regeneration industry. The acquisition of Datum Dental will open up significant opportunities for Dentsply Sirona within its Implants segment. In addition, Datum Dental has a strong R&D pipeline with many promising products with differentiated value propositions and Dentsply Sirona has the capacity to further invest in its future development. ![]() Datum Dental complements Dentsply Sirona’s existing implant dentistry strategy around Ankylos, Astra Tech Implant System, Xive and Atlantis, focusing on established quality and meaningful innovation. Datum Dental is an Israel-based company, known for its innovative dental regeneration products with the clinically superior proprietary technology GLYMATRIX®. ![]() with its strong OSSIX® biomaterial portfolio. The transaction is expected to close in January 2021, following customary approval requirements.Dentsply Sirona acquires Datum Dental, a leading provider of the innovative OSSIX ® regenerative solutions portfolio Posted on Thursday, January 21, 2021ĭentsply Sirona today announced that it has acquired Datum Dental, Ltd. The strong OSSIX portfolio will be the foundation of the Regenerative portfolio of Dentsply Sirona. Today, Dentsply Sirona is promoting the full OSSIX portfolio (OSSIX®Plus, OSSIX® Volumax, and OSSIX™ Bone) in the U.S., Canada, Colombia, France, Belgium, UK-Ireland, Nordics, Poland, Romania, Turkey and Hong Kong.Ĭlinicians will benefit in the future from OSSIX products’ being implemented in a broad set of solutions and workflows and Dentsply Sirona’s capacity to invest in the future development, the companies state. The biomaterial sector is an important cornerstone of the future of dentistry, according to Dentsply Sirona, and this acquisition is another important step to deliver on the company’s purpose to empower dental professionals to provide patients with better dental care and make people smile, according to Gene Dorff, Group Vice President Implants Product Group of Dentsply Sirona.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |